Wall Street rallies on promising coronavirus drug

Go back to Wall Street rallies on promising coronavirus drug

Facebook (FB) PT Raised to $245 at Mizuho Securities Following COVID-19 Impact

April 30, 2020 7:07 AM EDT

Mizuho Securities analyst James Lee raised the price target on Facebook (NASDAQ: FB) to $245.00 (from $220.00) while maintaining a Buy rating. The COVID-19 impact was clearly negative for advertising, but trends in April are much better, at flat YoY, than agency checks at mid-teens... More

Microsoft (MSFT) PT Raised to $205 at Mizuho Securities Following 3Q Report

April 30, 2020 7:02 AM EDT

Mizuho Securities analyst Gregg Moskowitz raised the price target on Microsoft (NASDAQ: MSFT) to $205.00 (from $200.00) while maintaining a Buy rating following the company's 3Q earnings report. F3Q revenue and EPS of $35B and $1.40 were well above Street forecasts of $33.9B and $1.29, respectively.... More

Tesla (TSLA) PT Raised to $600 at Wedbush

April 30, 2020 7:02 AM EDT

Wedbush analyst Daniel Ives raised the price target on Tesla (NASDAQ: TSLA) to $600.00 (from $425.00) while maintaining a Neutral rating.

... More

Microsoft (MSFT) PT Raised to $213 at Bernstein

April 30, 2020 6:52 AM EDT

Bernstein analyst Mark Moerdler raised the price target on Microsoft (NASDAQ: MSFT) to $213.00 (from $201.00) while maintaining a Outperform rating.

... More